Enzalutamide
- OralEnzalutamideXtandi
- Mechanism of Action
- Directly inhibits the binding of androgens to androgen receptors.
- Pharmacology
- Interacts only with androgen receptors, producing no progestin or glucocorticoid effects.
Clinical Use
- Indication
- Androgen deprivation therapy for metastatic castrate-resistant prostate cancer.
- Contraindications
- Seizure disorders.
- Adverse Effects